Clinical trials
Participation clinical trials
Below are recruiting participation clinical trials, each written for real people, not researchers. We’re tracking 2,283 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07832292RecruitingPhase 2
Study of an investigational drug for metastatic prostate cancer
This trial tests an experimental drug (JNJ-101556143) for men with metastatic prostate cancer that has stopped responding to hormone therapy. The goal is to see if this drug can slow down or stop the cancer from growing.
Lafayette, LouisianaAges 18 years+ - NCT07828392Recruiting
Calf tightness and foot touch sensitivity study
This study looks at how calf muscle tightness relates to foot sensitivity. It may help understand the link between muscle tightness and touch sensations in the feet.
NiğdeAges 18–65 - NCT07817875RecruitingPhase 3
Tirzepatide for weight loss in children aged 6 to under 12
This study tests a once-weekly medication called tirzepatide to help children aged 6 to under 12 with obesity lose weight. It compares the medication to a placebo (inactive shot) to see if it safely helps with weight loss in this age group.
Tucson, ArizonaAges 6–11 - NCT07819136RecruitingPhase 1/Phase 2
REC-7735 for people with advanced solid tumors
This study tests a new drug called REC-7735 for people with solid tumors that have a specific genetic change (PIK3CA H1047R). The drug targets this change to try to stop the cancer from growing.
Grand Rapids, MichiganAges 18 years+ - NCT07821658Recruiting
Lecanemab treatment study for Alzheimer's disease
This study looks at people who are taking or have taken lecanemab (a medication for Alzheimer's disease). It aims to gather more information about the treatment's effects in real-world settings.
Nutley, New JerseyAges Any age - NCT07819097RecruitingPhase 3
RSV vaccine study for healthy older adults
This study tests an RSV vaccine to see if it is safe and helps your immune system fight the virus. It's for older adults who are generally healthy, and it may help protect you from severe RSV illness.
Scottsdale, ArizonaAges 60 years+ - NCT07822919RecruitingPhase 1
Study of AWT020 for advanced solid tumors
This trial tests an investigational drug called AWT020 for people with advanced solid tumors that have grown after standard treatment. The goal is to see if AWT020 can help shrink or control the cancer, and it might be an option for you if other treatments haven't worked or aren't suitable.
Plantation, FloridaAges 18 years+ - NCT07818967RecruitingPhase 1
A study of abemaciclib in healthy volunteers
This study tests how a medicine called abemaciclib is processed by the body in healthy people. It helps researchers understand the drug's effects and safety before it is used in patients.
SingaporeAges 21 years+ - NCT07822529Recruiting
Long-term study of Tremfya for inflammatory bowel disease
This study follows adults with moderate-to-severe Crohn's disease or ulcerative colitis who are starting treatment with guselkumab (Tremfya). It aims to see how well the medication works and how long the effects last over time.
AmiensAges 18 years+ - NCT07820085RecruitingPhase 2/Phase 3
Oral treatment for light sensitivity in EPP and XLP
This study tests an oral medication, PORT-77, to reduce pain and sensitivity to sunlight in people with EPP or XLP. It may help those who experience symptoms shortly after sun exposure.
Huntington Beach, CaliforniaAges 12 years+ - NCT07824271RecruitingPhase 1
Testing the safety of ALZ-507 in healthy older adults
This study tests a new oral drug called ALZ-507, which is being developed for Alzheimer's disease. It is an early-phase trial to check the drug's safety and how it is processed in the body, in healthy older adults.
Miami, FloridaAges 50–75 - NCT07823205RecruitingPhase 1
Oral KT-621 study for healthy volunteers
This trial tests a new oral medication, KT-621, given as different tablet or capsule forms. It helps researchers understand how the body handles the drug, which is the first step toward future treatments.
Lincoln, NebraskaAges 18–55 - NCT07809802RecruitingPhase 1
Study of vorolanib tablets in people with liver problems
This study looks at how the body handles the study drug vorolanib (taken as a tablet) when your liver is impaired. It might help doctors understand the right dose for people with liver problems, and it may also benefit those who are newly diagnosed or exploring treatment options.
Changchun, JilinAges 18–70 - NCT07815067RecruitingPhase 1
Meal timing and water intake with Zenagamtide for overweight or obesity
This study tests how the timing of your meal and how much water you drink with the medicine affect how your body absorbs a new medicine called Zenagamtide. If you have overweight or obesity, this could help find the best way to take the medicine for maximum effect.
BerlinAges 18 years+ - NCT07809815RecruitingPhase 1
Drug interaction study of befotertinib in healthy volunteers
This study checks how befotertinib, an experimental cancer drug, interacts with other drugs in healthy people. It helps make sure the drug is safe and works well when taken with other medicines.
Hangzhou, ZhejiangAges 18–45 - NCT07809789RecruitingPhase 1
Vorolanib drug interaction study in healthy volunteers
This study checks how the experimental cancer drug vorolanib interacts with other medicines when taken together. It is for healthy people to help find the right dose and safety information before it is tested in patients.
Hangzhou, ZhejiangAges 18–45 - NCT07811869RecruitingPhase 3
Remibrutinib for severe itchy skin with unknown cause
This study tests a new medicine called remibrutinib to see if it can reduce severe itching that has no clear cause. It aims to help people whose daily itching is very intense and not relieved by standard creams.
Tampa, FloridaAges 18 years+ - NCT07811999RecruitingPhase 1
One injection vs two for a bone medicine
This study compares how the body absorbs romosozumab (a medicine for bone loss) when given as one injection versus two injections. It's for healthy adults to check side effects and how the drug behaves, which is the first step before it could be used for conditions like osteoporosis.
Miami, FloridaAges 18–60 - NCT07812090RecruitingPhase 2
Oral medication for diabetic macular edema
This study tests an oral medication that may reduce swelling in the retina caused by diabetes. If you have diabetic macular edema affecting your central vision, this trial could help you preserve or improve your sight.
McAllen, TexasAges 18–75 - NCT07811193RecruitingPhase 2
Study of new drug combined with immunotherapy for advanced bowel cancer
This trial tests a new drug (VVD-133214) combined with an existing immunotherapy (pembrolizumab) for advanced colorectal cancer that is mismatch repair deficient. It aims to see if the combination works better than pembrolizumab alone in shrinking or controlling the cancer.
Tucson, ArizonaAges 18 years+ - NCT07811908RecruitingPhase 2
Testing a new malaria treatment for children
This study tests a new malaria treatment for children with mild (uncomplicated) malaria. The goal is to see if the treatment safely and effectively clears the infection.
BanforaAges 2–12 - NCT07815496Recruiting
Study of oxytocin on fairness and helping behavior
This study tests whether the hormone oxytocin (given as a nasal spray) changes how you perceive fairness and how you behave toward others. It may help researchers understand how this natural hormone influences social decisions.
Chengdu, SichuanAges 18–35 - NCT07803809RecruitingPhase 1
MWN105 injection for overweight and obesity
This study tests an investigational injection called MWN105 in people who are overweight or obese but do not have diabetes. The goal is to see if it is safe and helps with weight loss.
Kunming, YunnanAges 18–50 - NCT07808073RecruitingPhase 1
A weight-loss medicine study for people with overweight or obesity
This study tests an experimental medicine (LY4329090) to see if it can help people with overweight or obesity lose weight. You would be monitored closely for safety, and you may or may not receive the study drug.
Daytona Beach, FloridaAges 18–65
Hear when a new Participation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for participation?
- Yes. Clin2 currently lists 2,283 recruiting participation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a participation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a participation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.